Beckman Coulter: CAR-T Cells 101

Immunotherapy's key effector cells

The Scientist Creative Services Team
Mar 26, 2018

The basics of CAR T-cell therapy

As immunotherapies pick up steam in the clinic, more researchers are turning to immune-modulation methods to solve long-standing challenges. At the center of the immune system's response to cancer are T cells. Find out how T cells could provide new solutions in the face of cancer's ever-evolving attacks. Will chimeric antigen receptor-expressing T cells lead the drive to cancer eradication? beckman.com/resources

Interested in reading more?

Beckman Coulter: CAR-T Cells 101

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?